Live Breaking News & Updates on Personalized Stem Cells

Stay updated with breaking news from Personalized stem cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Personalized Stem Cells Announces First Patients Treated in COVID-19 Clinical Trial Licensed to Sorrento Therapeutics


Personalized Stem Cells Announces First Patients Treated in COVID-19 Clinical Trial Licensed to Sorrento Therapeutics
Personalized Stem Cells, Inc. announces first patients treated in COVID-19 FDA approved stem cell clinical trial licensed to Sorrento Therapeutics.
POWAY, CALIFORNIA, US, February 3, 2021 /EINPresswire.com/ Personalized Stem Cells, Inc (PSC), a human adipose-derived stem cell company, announces that the first patients have received stem cell therapy for the treatment of COVID-19 as part of an FDA approved clinical trial. The ongoing clinical trial and stem cell platform, which PSC developed and then licensed to Sorrento Therapeutics (Nasdaq: SRNE, Sorrento ), is being conducted at UCSF Fresno. The objective of this non-randomized, Phase 1b study is to evaluate the safety and preliminary efficacy of adipose-derived stem cell therapy for the treatment of acute respiratory distress syndrome (ARDS) resulting from infection with COVID-19. ....

United States , Vetstem Biopharma , Calidi Biotherapeutics , Personalized Stem Cells Inc , White House Coronavirus Task , Personalized Stem Cells , Stem Cells , Sorrento Therapeutics , Performance Cell Manufacturing , San Diego Based , White House Coronavirus Task Force , Investigational New Drug , San Diego , ஒன்றுபட்டது மாநிலங்களில் , தனிப்பயனாக்கப்பட்டது தண்டு செல்கள் இன்க் , தனிப்பயனாக்கப்பட்டது தண்டு செல்கள் , தண்டு செல்கள் , ஸாரெஂடோ சிகிச்சை , செயல்திறன் செல் உற்பத்தி , சான் டியாகோ அடிப்படையிலானது , சான் டியாகோ ,